Slow-release 'jelly' is novel drug deliverer

Wednesday, January 30, 2013

Mark N. Feinglos, MD, CM, professor of medicine (Endocrinology, Metabolism and Nutrition) and associate professor of Pathology and Psychiatry and Behavioral Sciences, is part of a team of Duke researchers who have developed a new method to overcome major hurdles facing a promising new class of peptide drugs to treat diseases such as diabetes and cancer.